FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
(Updated - February 10, 2026 6:49 AM EST)
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $2.42, $0.06 better than the analyst estimate of $2.36. Revenue for the quarter came in at $2.81 billion versus the consensus estimate of $2.75 billion.
GUIDANCE:
Quest Diagnostics sees FY2026 EPS of... More

